Artificial Intelligence and Disease Modeling: Focus on Neurological Disorders

Clin Pharmacol Ther. 2024 Mar 13. doi: 10.1002/cpt.3253. Online ahead of print.

Authors

Benjamin Ribba¹, Gennaro Pagano¹, Niklas Korsbo², Vijay Ivaturi², Antoine Soubret¹

Affiliations

¹ Roche Pharma Research and Early Development (pRED), F. Hoffmann-La Roche Ltd., Basel, Switzerland.
² PumasAI, Inc., Dover, Delaware, USA.

PMID: 38480479
DOI: 10.1002/cpt.3253

No abstract available